← Back to Search

Mindfulness & Tai Chi for Cancer Health (MATCH Trial)

N/A
Waitlist Available
Led By Linda E Carlson, PhD
Research Sponsored by Linda E. Carlson
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention, within 3 weeks of completion of the intervention, 6-month follow up from intervention completion
Awards & highlights

MATCH Trial Summary

This trial is testing whether mindfulness-based cancer recovery or Tai chi/Qigong are more effective than usual care in improving quality of life for cancer survivors.

Who is the study for?
This trial is for adults over 18 who've had cancer (stage I-III, excluding head, neck, or brain), finished active treatment at least 4 months ago, and can attend classes. They should be able to do light physical activity and speak English well enough for questionnaires and groups. It's not for those with severe mental health issues, cognitive impairments, metastatic cancer patients on chemotherapy, or those already practicing meditation or tai chi weekly.Check my eligibility
What is being tested?
The MATCH Study compares Mindfulness-Based Cancer Recovery (MBCR) and Tai Chi/Qigong (TCQ) against a waitlist control to see which improves quality of life after cancer. Participants either choose their preferred method or are randomly assigned one if they have no preference. The study measures mood, stress levels, physical function before/after the intervention and at a 6-month follow-up.See study design
What are the potential side effects?
Since MBCR involves mindfulness practices and TCQ includes gentle movements focused on breath control and flexibility there are minimal risks involved. However participants may experience emotional discomfort when discussing personal experiences during sessions.

MATCH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention, within 3 weeks of completion of the intervention, 6-month follow up from intervention completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention, within 3 weeks of completion of the intervention, 6-month follow up from intervention completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Profile of Mood States - Total Mood Disturbance (POMS-TMD)
Secondary outcome measures
Average Diurnal Cortisol Slope
Blood Pressure
Brief Pain Inventory
+16 more

MATCH Trial Design

8Treatment groups
Experimental Treatment
Active Control
Group I: Preference: TCQ (im)Experimental Treatment1 Intervention
Individuals with a preference for 'Tai Chi/Qigong (TCQ) for Cancer Patients' randomized to immediate treatment
Group II: Preference: MBCR (im)Experimental Treatment1 Intervention
Individuals with a preference for 'Mindfulness-Based Cancer Recovery (MBCR)' randomized to immediate treatment
Group III: No Preference: TCQ (im)Experimental Treatment1 Intervention
Individuals with no preference randomized to 'Tai Chi/Qigong (TCQ) for Cancer Patients' - immediate
Group IV: No Preference: MBCR (im)Experimental Treatment1 Intervention
Individuals with no preference randomized to 'Mindfulness-Based Cancer Recovery (MBCR)' - immediate
Group V: Preference: MBCR (wl)Active Control1 Intervention
Individuals with a preference for 'Mindfulness-Based Cancer Recovery (MBCR)' randomized to waitlist
Group VI: No Preference: MBCR (wl)Active Control1 Intervention
Individuals with no preference randomized to 'Mindfulness-Based Cancer Recovery (MBCR)' - waitlist
Group VII: No Preference: TCQ (wl)Active Control1 Intervention
Individuals with no preference randomized to 'Tai Chi/Qigong (TCQ) for Cancer Patients' - waitlist
Group VIII: Preference: TCQ (wl)Active Control1 Intervention
Individuals with a preference for 'Tai Chi/Qigong (TCQ) for Cancer Patients' randomized to waitlist

Find a Location

Who is running the clinical trial?

Linda E. CarlsonLead Sponsor
University of CalgaryOTHER
791 Previous Clinical Trials
868,134 Total Patients Enrolled
Alberta Health servicesOTHER
157 Previous Clinical Trials
648,944 Total Patients Enrolled

Media Library

Mindfulness Based Cancer Recovery (MBCR) Clinical Trial Eligibility Overview. Trial Name: NCT02801123 — N/A
Cancer Research Study Groups: Preference: MBCR (im), Preference: TCQ (im), Preference: MBCR (wl), No Preference: MBCR (im), No Preference: TCQ (im), No Preference: MBCR (wl), No Preference: TCQ (wl), Preference: TCQ (wl)
Cancer Clinical Trial 2023: Mindfulness Based Cancer Recovery (MBCR) Highlights & Side Effects. Trial Name: NCT02801123 — N/A
Mindfulness Based Cancer Recovery (MBCR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02801123 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available opportunities for patients to participate in this trial?

"This trial, which was originally listed on August 29th 2016 and updated last May 19th 2022, is no longer open for enrollment. However, there are 486 other trials actively looking to recruit volunteers as of now."

Answered by AI
~70 spots leftby Apr 2025